Seo Salimi

Seo Salimi is a partner and the Co-Head of Equity Capital Markets and Co-Chair of the Corporate Life Science Group of Paul Hastings and is based in the firm's New York office. His practice focuses on representing life science companies and investment banks in public and private capital markets transactions, such as initial public offerings, follow-on offerings, at-the-market transactions, and private placements. Mr. Salimi has extensive experience in cross-border financing transactions, representing issuers and investment banks in complex dual listings and cross border initial public offerings and follow-on offerings. Mr. Salimi is a trusted advisor to both public and private companies in their capital raising strategy and ongoing corporate matters, including SEC compliance and corporate governance. Mr. Salimi has been recognized as a “Next Generation Partner” for Capital Markets: Equity by The Legal 500 US, where clients note he is “committed, hard-working and driven; his ability to manage across his team, both up and down, as well as his interactions with counsel from the other party makes [Mr. Salimi] invaluable.” In 2020, Mr. Salimi was nominated for the “US Rising Star – Financial & Corporate” award by LMG Life Sciences. · Paul Hastings LLP

United StatesEquity Capital Markets, Corporate Life Sciences

Email Call

About

Seo Salimi is a partner, Co-Head of Equity Capital Markets, and Co-Chair of the Corporate Life Science Group at Paul Hastings LLP in New York. He represents life science companies and investment banks in public and private capital markets transactions, including IPOs, follow-on offerings, at-the-market offerings, private placements, and cross-border financings. He also advises on SEC compliance and corporate governance.

Practice areas

Equity Capital MarketsCorporate Life SciencesSEC ComplianceCorporate Governance

Office

United States

Paul Hastings LLP · Seo Salimi is a partner and the Co-Head of Equity Capital Markets and Co-Chair of the Corporate Life Science Group of Paul Hastings and is based in the firm's New York office. His practice focuses on representing life science companies and investment banks in public and private capital markets transactions, such as initial public offerings, follow-on offerings, at-the-market transactions, and private placements. Mr. Salimi has extensive experience in cross-border financing transactions, representing issuers and investment banks in complex dual listings and cross border initial public offerings and follow-on offerings. Mr. Salimi is a trusted advisor to both public and private companies in their capital raising strategy and ongoing corporate matters, including SEC compliance and corporate governance. Mr. Salimi has been recognized as a “Next Generation Partner” for Capital Markets: Equity by The Legal 500 US, where clients note he is “committed, hard-working and driven; his ability to manage across his team, both up and down, as well as his interactions with counsel from the other party makes [Mr. Salimi] invaluable.” In 2020, Mr. Salimi was nominated for the “US Rising Star – Financial & Corporate” award by LMG Life Sciences.

United States

Expertise

Initial Public OfferingsFollow-On OfferingsAt-the-Market OfferingsPrivate PlacementsCross-Border FinancingSEC ComplianceCorporate Governance

Education

University of Southern California Gould School of Law, J.D., 2004
University of California, Irvine, B.A., 2001